Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome.
Gupta, S, Aggarwal, S, See, D et al. · Journal of psychiatric research · 1997 · DOI
Quick Summary
Researchers tested immune cells from people with ME/CFS to measure inflammation-related proteins called cytokines. They found that certain immune cells from ME/CFS patients produced higher levels of inflammatory proteins (TNF-alpha and IL-6) without any stimulation, but produced lower levels of a protective protein (IL-10) compared to healthy people. These imbalances might explain some of the symptoms people with ME/CFS experience.
Why It Matters
Cytokine dysregulation has been proposed as a mechanism underlying ME/CFS symptoms including fatigue, pain, and cognitive dysfunction. Identifying specific patterns of immune activation may eventually lead to biomarkers for diagnosis or therapeutic targets, though this early work requires replication and expansion.
Observed Findings
Spontaneous TNF-alpha production by non-adherent lymphocytes was significantly elevated in ME/CFS patients compared to controls
Spontaneous IL-6 production by both monocytes and lymphocytes was significantly elevated, confirmed at both protein and mRNA levels
Spontaneous IL-10 production by both adherent and non-adherent cells was significantly decreased in ME/CFS patients
PHA-stimulated IL-10 production by lymphocytes was also significantly decreased
No significant differences were reported in other measured cytokine responses under stimulated conditions
Inferred Conclusions
An aberrant pattern of cytokine production exists in ME/CFS characterized by excessive spontaneous pro-inflammatory cytokine release and deficient anti-inflammatory cytokine production
This cytokine dysregulation may mechanistically contribute to clinical manifestations of ME/CFS
Altered immune cell function in ME/CFS may reflect a persistent activation or dysregulation of immune tolerance mechanisms
Remaining Questions
Are these cytokine abnormalities present in all ME/CFS patients or only specific subsets, and do they correlate with symptom severity or disease subtypes?
Do these cytokine patterns precede ME/CFS onset, persist over time, or change with disease course and treatment?
What This Study Does Not Prove
This study does not prove that cytokine imbalance causes ME/CFS symptoms—it shows an association only. It cannot determine whether the altered cytokine profile is a primary cause, a secondary consequence of other pathological processes, or influenced by other factors like infections or stress. The small sample size and preliminary nature mean findings require validation in larger, well-controlled studies.
What causes the underlying immune dysregulation—is it a primary immune defect, triggered by infection, or secondary to other pathological processes?
Do these specific cytokine abnormalities directly cause clinical symptoms through recognized biological mechanisms, or are they markers of other pathological changes?